Rough Draft Atlanta on MSN4h
Researchers expect FDA to approve a twice-yearly shot that reduces risk of HIV infection by 96%Roughly 61,000 Georgians live with HIV, the sexually transmitted virus (STI) that can lead to AIDS, and Atlanta ranks in the ...
WHO is convening a Guideline Development Group (GDG) for the development of new guidelines on the use of injectable ...
We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will ...
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States ...
The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...
Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
Nov. 27, 2024 — Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring ... HIV Latency Reversing ...
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
What new medicines are poised to take the leap from breakthrough to approval in 2025? Here’s what to expect this year.
Global partners have supported Africa’s progress in HIV vaccine research and development. Organisations such as the US ...
5dOpinion
The renaissance of the Notre-Dame Cathedral: A half-decade ago, the world watched in horror as Notre-Dame de Paris burned.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback